Study champions active surveillance in prostate cancer

Men with low-grade prostate cancers can be assured that active surveillance will help avoid overtreatment without risking their mortality, say US researchers.

A prospective study of 1298 men deemed at low or very low risk of prostate cancer progression put on active surveillance found that only five men (0.4%) had metastases or died as a result of prostate cancer during a median of 5 years of follow-up.